https://theusajournals.com/index.php/ajbspi <p><strong>American Journal Of Biomedical Science &amp; Pharmaceutical Innovation (<span class="ng-scope"><span class="ng-binding ng-scope">2771-2753</span></span>)</strong></p> <p><strong>Open Access International Journal</strong></p> <p><strong>Last Submission:- 25th of Every Month</strong></p> <p><strong>Frequency: 12 Issues per Year (Monthly)</strong></p> <p> </p> Oscar Publishing Services en-US American Journal Of Biomedical Science & Pharmaceutical Innovation 2771-2753 https://theusajournals.com/index.php/ajbspi/article/view/11437 <p>Diabetes mellitus is a complex metabolic disorder associated with persistent hyperglycemia, oxidative stress, and progressive impairment of multiple physiological systems, including male reproductive function. Diabetic-induced testicular dysfunction has emerged as a significant complication characterized by disrupted hormonal regulation, impaired spermatogenesis, oxidative damage, and reduced reproductive capacity. Natural medicinal resources with antioxidant and glucose-regulating properties have gained considerable attention as potential therapeutic alternatives for mitigating diabetes-associated complications. Vernonia amygdalina, a widely utilized medicinal plant in African traditional medicine, contains bioactive phytoconstituents with reported antidiabetic, antioxidant, and protective biological activities. This research examines the antidiabetic and testoprotective potential of Vernonia amygdalina in alloxan-induced diabetic male Wistar rats through an integrated evaluation of metabolic regulation, oxidative stress modulation, and reproductive tissue preservation. The study framework is based on the hypothesis that ethanolic extract of Vernonia amygdalina may reduce hyperglycemia-induced cellular injury by enhancing antioxidant defense mechanisms and maintaining testicular structural and functional integrity. Previous investigations demonstrate that diabetes negatively affects male reproductive physiology through alterations in insulin signaling, gonadotropin regulation, and oxidative imbalance (Ballester et al., 2004; Jangir &amp; Jain, 2014). Evidence regarding Vernonia amygdalina indicates significant therapeutic activity against diabetic complications, particularly through regulation of oxidative biomarkers and improvement of endogenous antioxidant systems (Asante &amp; Wiafe, 2023; Edo et al., 2024). The findings from the proposed analytical framework highlight the potential of Vernonia amygdalina as a multifunctional botanical intervention for diabetes-associated reproductive complications. This research contributes to the growing scientific understanding of plant-based approaches in managing metabolic disorders and provides a foundation for further pharmacological investigations.</p> Dr. Ayesha Rahman Copyright (c) 2026 Dr. Ayesha Rahman https://creativecommons.org/licenses/by/4.0 2026-08-01 2026-08-01 6 08 1 11 https://theusajournals.com/index.php/ajbspi/article/view/11497 <p>Migraine and ischemic heart disease are among the most common conditions, significantly impacting quality of life and overall morbidity. Although these conditions are traditionally considered independent entities, recent research suggests common mechanisms underlying their development.</p> Khatamova Nasiba Baxromjon Qizi Karataeva Lola Abdullaevna Copyright (c) 2026 Khatamova Nasiba Baxromjon Qizi, Karataeva Lola Abdullaevna https://creativecommons.org/licenses/by/4.0 2026-08-12 2026-08-12 6 08 12 16 10.37547/ajbspi/Volume06Issue08-02